Global Sickle Cell Disease Treatments Market Insights, Forecast to 2031

Report ID: 1652990 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sickle Cell Disease Treatments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Infection Prevention with Vaccination and Antibiotics
        1.2.3 Blood Transfusion
        1.2.4 The Medication Hydroxycarbamide
        1.2.5 A Transplant of Bone Marrow Cells
    1.3 Market by Application
        1.3.1 Global Sickle Cell Disease Treatments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Clinics
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sickle Cell Disease Treatments Market Perspective (2017-2028)
    2.2 Sickle Cell Disease Treatments Growth Trends by Region
        2.2.1 Sickle Cell Disease Treatments Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Sickle Cell Disease Treatments Historic Market Size by Region (2017-2022)
        2.2.3 Sickle Cell Disease Treatments Forecasted Market Size by Region (2023-2028)
    2.3 Sickle Cell Disease Treatments Market Dynamics
        2.3.1 Sickle Cell Disease Treatments Industry Trends
        2.3.2 Sickle Cell Disease Treatments Market Drivers
        2.3.3 Sickle Cell Disease Treatments Market Challenges
        2.3.4 Sickle Cell Disease Treatments Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sickle Cell Disease Treatments Players by Revenue
        3.1.1 Global Top Sickle Cell Disease Treatments Players by Revenue (2017-2022)
        3.1.2 Global Sickle Cell Disease Treatments Revenue Market Share by Players (2017-2022)
    3.2 Global Sickle Cell Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sickle Cell Disease Treatments Revenue
    3.4 Global Sickle Cell Disease Treatments Market Concentration Ratio
        3.4.1 Global Sickle Cell Disease Treatments Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatments Revenue in 2021
    3.5 Sickle Cell Disease Treatments Key Players Head office and Area Served
    3.6 Key Players Sickle Cell Disease Treatments Product Solution and Service
    3.7 Date of Enter into Sickle Cell Disease Treatments Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Treatments Breakdown Data by Type
    4.1 Global Sickle Cell Disease Treatments Historic Market Size by Type (2017-2022)
    4.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2023-2028)
5 Sickle Cell Disease Treatments Breakdown Data by Application
    5.1 Global Sickle Cell Disease Treatments Historic Market Size by Application (2017-2022)
    5.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Sickle Cell Disease Treatments Market Size (2017-2028)
    6.2 North America Sickle Cell Disease Treatments Market Size by Type
        6.2.1 North America Sickle Cell Disease Treatments Market Size by Type (2017-2022)
        6.2.2 North America Sickle Cell Disease Treatments Market Size by Type (2023-2028)
        6.2.3 North America Sickle Cell Disease Treatments Market Share by Type (2017-2028)
    6.3 North America Sickle Cell Disease Treatments Market Size by Application
        6.3.1 North America Sickle Cell Disease Treatments Market Size by Application (2017-2022)
        6.3.2 North America Sickle Cell Disease Treatments Market Size by Application (2023-2028)
        6.3.3 North America Sickle Cell Disease Treatments Market Share by Application (2017-2028)
    6.4 North America Sickle Cell Disease Treatments Market Size by Country
        6.4.1 North America Sickle Cell Disease Treatments Market Size by Country (2017-2022)
        6.4.2 North America Sickle Cell Disease Treatments Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Sickle Cell Disease Treatments Market Size (2017-2028)
    7.2 Europe Sickle Cell Disease Treatments Market Size by Type
        7.2.1 Europe Sickle Cell Disease Treatments Market Size by Type (2017-2022)
        7.2.2 Europe Sickle Cell Disease Treatments Market Size by Type (2023-2028)
        7.2.3 Europe Sickle Cell Disease Treatments Market Share by Type (2017-2028)
    7.3 Europe Sickle Cell Disease Treatments Market Size by Application
        7.3.1 Europe Sickle Cell Disease Treatments Market Size by Application (2017-2022)
        7.3.2 Europe Sickle Cell Disease Treatments Market Size by Application (2023-2028)
        7.3.3 Europe Sickle Cell Disease Treatments Market Share by Application (2017-2028)
    7.4 Europe Sickle Cell Disease Treatments Market Size by Country
        7.4.1 Europe Sickle Cell Disease Treatments Market Size by Country (2017-2022)
        7.4.2 Europe Sickle Cell Disease Treatments Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sickle Cell Disease Treatments Market Size (2017-2028)
    8.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type
        8.2.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Sickle Cell Disease Treatments Market Share by Type (2017-2028)
    8.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application
        8.3.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Sickle Cell Disease Treatments Market Share by Application (2017-2028)
    8.4 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region
        8.4.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Sickle Cell Disease Treatments Market Size (2017-2028)
    9.2 Latin America Sickle Cell Disease Treatments Market Size by Type
        9.2.1 Latin America Sickle Cell Disease Treatments Market Size by Type (2017-2022)
        9.2.2 Latin America Sickle Cell Disease Treatments Market Size by Type (2023-2028)
        9.2.3 Latin America Sickle Cell Disease Treatments Market Share by Type (2017-2028)
    9.3 Latin America Sickle Cell Disease Treatments Market Size by Application
        9.3.1 Latin America Sickle Cell Disease Treatments Market Size by Application (2017-2022)
        9.3.2 Latin America Sickle Cell Disease Treatments Market Size by Application (2023-2028)
        9.3.3 Latin America Sickle Cell Disease Treatments Market Share by Application (2017-2028)
    9.4 Latin America Sickle Cell Disease Treatments Market Size by Country
        9.4.1 Latin America Sickle Cell Disease Treatments Market Size by Country (2017-2022)
        9.4.2 Latin America Sickle Cell Disease Treatments Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sickle Cell Disease Treatments Market Size (2017-2028)
    10.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type
        10.2.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Sickle Cell Disease Treatments Market Share by Type (2017-2028)
    10.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application
        10.3.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Sickle Cell Disease Treatments Market Share by Application (2017-2028)
    10.4 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country
        10.4.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Sickle Cell Disease Treatments Introduction
        11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.1.5 AstraZeneca Recent Developments
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Sickle Cell Disease Treatments Introduction
        11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.2.5 Eli Lilly Recent Developments
    11.3 Bristol-Myers Squibb
        11.3.1 Bristol-Myers Squibb Company Details
        11.3.2 Bristol-Myers Squibb Business Overview
        11.3.3 Bristol-Myers Squibb Sickle Cell Disease Treatments Introduction
        11.3.4 Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.3.5 Bristol-Myers Squibb Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Sickle Cell Disease Treatments Introduction
        11.4.4 Novartis Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Sickle Cell Disease Treatments Introduction
        11.5.4 Pfizer Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.5.5 Pfizer Recent Developments
    11.6 Baxter
        11.6.1 Baxter Company Details
        11.6.2 Baxter Business Overview
        11.6.3 Baxter Sickle Cell Disease Treatments Introduction
        11.6.4 Baxter Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.6.5 Baxter Recent Developments
    11.7 Emmaus Life Sciences
        11.7.1 Emmaus Life Sciences Company Details
        11.7.2 Emmaus Life Sciences Business Overview
        11.7.3 Emmaus Life Sciences Sickle Cell Disease Treatments Introduction
        11.7.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.7.5 Emmaus Life Sciences Recent Developments
    11.8 Bluebird Bio
        11.8.1 Bluebird Bio Company Details
        11.8.2 Bluebird Bio Business Overview
        11.8.3 Bluebird Bio Sickle Cell Disease Treatments Introduction
        11.8.4 Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.8.5 Bluebird Bio Recent Developments
    11.9 Global Blood Therapeutics
        11.9.1 Global Blood Therapeutics Company Details
        11.9.2 Global Blood Therapeutics Business Overview
        11.9.3 Global Blood Therapeutics Sickle Cell Disease Treatments Introduction
        11.9.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.9.5 Global Blood Therapeutics Recent Developments
    11.10 Sangamo Therapeutics
        11.10.1 Sangamo Therapeutics Company Details
        11.10.2 Sangamo Therapeutics Business Overview
        11.10.3 Sangamo Therapeutics Sickle Cell Disease Treatments Introduction
        11.10.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.10.5 Sangamo Therapeutics Recent Developments
    11.11 Acceleron Pharma
        11.11.1 Acceleron Pharma Company Details
        11.11.2 Acceleron Pharma Business Overview
        11.11.3 Acceleron Pharma Sickle Cell Disease Treatments Introduction
        11.11.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.11.5 Acceleron Pharma Recent Developments
    11.12 Arena Pharmaceuticals
        11.12.1 Arena Pharmaceuticals Company Details
        11.12.2 Arena Pharmaceuticals Business Overview
        11.12.3 Arena Pharmaceuticals Sickle Cell Disease Treatments Introduction
        11.12.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.12.5 Arena Pharmaceuticals Recent Developments
    11.13 Alnylam Pharmaceuticals
        11.13.1 Alnylam Pharmaceuticals Company Details
        11.13.2 Alnylam Pharmaceuticals Business Overview
        11.13.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatments Introduction
        11.13.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2017-2022)
        11.13.5 Alnylam Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Sickle Cell Disease Treatments Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Infection Prevention with Vaccination and Antibiotics
    Table 3. Key Players of Blood Transfusion
    Table 4. Key Players of The Medication Hydroxycarbamide
    Table 5. Key Players of A Transplant of Bone Marrow Cells
    Table 6. Global Sickle Cell Disease Treatments Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Sickle Cell Disease Treatments Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Sickle Cell Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Sickle Cell Disease Treatments Market Share by Region (2017-2022)
    Table 10. Global Sickle Cell Disease Treatments Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Sickle Cell Disease Treatments Market Share by Region (2023-2028)
    Table 12. Sickle Cell Disease Treatments Market Trends
    Table 13. Sickle Cell Disease Treatments Market Drivers
    Table 14. Sickle Cell Disease Treatments Market Challenges
    Table 15. Sickle Cell Disease Treatments Market Restraints
    Table 16. Global Sickle Cell Disease Treatments Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Sickle Cell Disease Treatments Revenue Share by Players (2017-2022)
    Table 18. Global Top Sickle Cell Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatments as of 2021)
    Table 19. Ranking of Global Top Sickle Cell Disease Treatments Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Sickle Cell Disease Treatments Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Sickle Cell Disease Treatments Product Solution and Service
    Table 23. Date of Enter into Sickle Cell Disease Treatments Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Sickle Cell Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2017-2022)
    Table 27. Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2023-2028)
    Table 29. Global Sickle Cell Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Sickle Cell Disease Treatments Revenue Share by Application (2017-2022)
    Table 31. Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Sickle Cell Disease Treatments Revenue Share by Application (2023-2028)
    Table 33. North America Sickle Cell Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Sickle Cell Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Sickle Cell Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Sickle Cell Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Sickle Cell Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Sickle Cell Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Sickle Cell Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Sickle Cell Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Sickle Cell Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Sickle Cell Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Sickle Cell Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Sickle Cell Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Sickle Cell Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Sickle Cell Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Sickle Cell Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Sickle Cell Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Sickle Cell Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Sickle Cell Disease Treatments Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Sickle Cell Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Sickle Cell Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Sickle Cell Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Sickle Cell Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Sickle Cell Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Sickle Cell Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Sickle Cell Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Sickle Cell Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Sickle Cell Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Sickle Cell Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Sickle Cell Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Sickle Cell Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 63. AstraZeneca Company Details
    Table 64. AstraZeneca Business Overview
    Table 65. AstraZeneca Sickle Cell Disease Treatments Product
    Table 66. AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 67. AstraZeneca Recent Developments
    Table 68. Eli Lilly Company Details
    Table 69. Eli Lilly Business Overview
    Table 70. Eli Lilly Sickle Cell Disease Treatments Product
    Table 71. Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 72. Eli Lilly Recent Developments
    Table 73. Bristol-Myers Squibb Company Details
    Table 74. Bristol-Myers Squibb Business Overview
    Table 75. Bristol-Myers Squibb Sickle Cell Disease Treatments Product
    Table 76. Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 77. Bristol-Myers Squibb Recent Developments
    Table 78. Novartis Company Details
    Table 79. Novartis Business Overview
    Table 80. Novartis Sickle Cell Disease Treatments Product
    Table 81. Novartis Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Developments
    Table 83. Pfizer Company Details
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Sickle Cell Disease Treatments Product
    Table 86. Pfizer Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 87. Pfizer Recent Developments
    Table 88. Baxter Company Details
    Table 89. Baxter Business Overview
    Table 90. Baxter Sickle Cell Disease Treatments Product
    Table 91. Baxter Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 92. Baxter Recent Developments
    Table 93. Emmaus Life Sciences Company Details
    Table 94. Emmaus Life Sciences Business Overview
    Table 95. Emmaus Life Sciences Sickle Cell Disease Treatments Product
    Table 96. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 97. Emmaus Life Sciences Recent Developments
    Table 98. Bluebird Bio Company Details
    Table 99. Bluebird Bio Business Overview
    Table 100. Bluebird Bio Sickle Cell Disease Treatments Product
    Table 101. Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 102. Bluebird Bio Recent Developments
    Table 103. Global Blood Therapeutics Company Details
    Table 104. Global Blood Therapeutics Business Overview
    Table 105. Global Blood Therapeutics Sickle Cell Disease Treatments Product
    Table 106. Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 107. Global Blood Therapeutics Recent Developments
    Table 108. Sangamo Therapeutics Company Details
    Table 109. Sangamo Therapeutics Business Overview
    Table 110. Sangamo Therapeutics Sickle Cell Disease Treatments Product
    Table 111. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 112. Sangamo Therapeutics Recent Developments
    Table 113. Acceleron Pharma Company Details
    Table 114. Acceleron Pharma Business Overview
    Table 115. Acceleron Pharma Sickle Cell Disease Treatments Product
    Table 116. Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 117. Acceleron Pharma Recent Developments
    Table 118. Arena Pharmaceuticals Company Details
    Table 119. Arena Pharmaceuticals Business Overview
    Table 120. Arena Pharmaceuticals Sickle Cell Disease Treatments Product
    Table 121. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 122. Arena Pharmaceuticals Recent Developments
    Table 123. Alnylam Pharmaceuticals Company Details
    Table 124. Alnylam Pharmaceuticals Business Overview
    Table 125. Alnylam Pharmaceuticals Sickle Cell Disease Treatments Product
    Table 126. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 127. Alnylam Pharmaceuticals Recent Developments
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sickle Cell Disease Treatments Market Share by Type: 2021 VS 2028
    Figure 2. Infection Prevention with Vaccination and Antibiotics Features
    Figure 3. Blood Transfusion Features
    Figure 4. The Medication Hydroxycarbamide Features
    Figure 5. A Transplant of Bone Marrow Cells Features
    Figure 6. Global Sickle Cell Disease Treatments Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Sickle Cell Disease Treatments Report Years Considered
    Figure 12. Global Sickle Cell Disease Treatments Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Sickle Cell Disease Treatments Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Sickle Cell Disease Treatments Market Share by Region: 2021 VS 2028
    Figure 15. Global Sickle Cell Disease Treatments Market Share by Players in 2021
    Figure 16. Global Top Sickle Cell Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatments as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatments Revenue in 2021
    Figure 18. North America Sickle Cell Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Sickle Cell Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 20. North America Sickle Cell Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 21. North America Sickle Cell Disease Treatments Market Size Share by Country (2017-2028)
    Figure 22. United States Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Sickle Cell Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Sickle Cell Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Sickle Cell Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Sickle Cell Disease Treatments Market Size Share by Country (2017-2028)
    Figure 28. Germany Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Sickle Cell Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Sickle Cell Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Sickle Cell Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Sickle Cell Disease Treatments Market Size Share by Region (2017-2028)
    Figure 38. China Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Sickle Cell Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Sickle Cell Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Sickle Cell Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Sickle Cell Disease Treatments Market Size Share by Country (2017-2028)
    Figure 48. Mexico Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Sickle Cell Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Sickle Cell Disease Treatments Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Sickle Cell Disease Treatments Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Sickle Cell Disease Treatments Market Size Share by Country (2017-2028)
    Figure 54. Turkey Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Sickle Cell Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 58. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 61. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 62. Baxter Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 63. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 64. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 65. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 66. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 67. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 68. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 69. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird Bio
Global Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
Frequently Asked Questions
Sickle Cell Disease Treatments report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sickle Cell Disease Treatments report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sickle Cell Disease Treatments report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sigmoidoscope

Sigmoidoscope market is segmented by players, region (country), by Type and by Application. Playe ... Read More

Signal Repeaters

Signal Repeaters market is segmented by Type and by Application. Players, stakeholders, and other ... Read More